“Proof-of-principle studies are critical in demonstrating Bio-RFID accuracy for non-invasive methods of medical diagnostics. This was an essential step toward achieving our goal of delivering the first FDA-cleared, truly non-invasive glucose monitoring device to the market,” said Ron Erickson, CEO and Chairman at Know Labs.

Seventy one (71) participants enrolled in a randomized, controlled, single-blind, multi-center study of the Yōni.Fit device in women with stress urinary incontinence.

The ENRICH trial results were accepted as a late-breaker and will be presented on Saturday, April 22 during an oral plenary session beginning at 8:30 a.m. PT (11:30 a.m. ET) by co-lead ENRICH investigator, Gustavo Pradilla, M.D., associate professor of neurosurgery at Emory University School of Medicine and chief of neurosurgery at Grady Memorial Hospital. 

The researchers found that as hair ages, sheds, and then repeatedly grows back, increasing numbers of McSCs get stuck in the stem cell compartment called the hair follicle bulge. There, they remain, do not mature into the transit-amplifying state, and do not travel back to their original location in the germ compartment, where WNT proteins would have prodded them to regenerate into pigment cells.

Data shows the achievement of the primary endpoint of decreasing esophageal intraepithelial eosinophil count and the positive impact on an array of histological measures of EoE. Favorable safety and tolerability profile consistent with Phase 1 trial results.